ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

Dana-Farber Cancer Institute · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
head-and-neck-cancer
head and neck cancer, head and neck squamous cell carcinoma, metastatic head and neck cancer, recurrent head and neck cancer, metastatic head-and-neck squamous-cell carcinoma, recurrent head and neck squamous cell carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 902128
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.